tetraethylene glycol

Tetraethylene glycol is a PEG-based PROTAC linker that can be oxidised as a substrate of polyethylene glycol dehydrogenase (Km = 10 mM).

Tetraethylene glycol monotosylate, a cleavable and acylhydrazone-based ADC linker, is utilized in the synthesis of antibody-drug conjugates (ADCs) [1].

Tetraethylene glycol monomethyl ether, a PEG-based PROTAC linker, is employed for the synthesis of PROTACs[1].

Tetraethylene glycol monohexadecyl ether, a PEG-based PROTAC linker, is suitable for synthesizing PROTACs.

Tetraethylene glycol monooctyl ether is a nonionic nonionic surfactant.

Tetraethylene Glycol Monohexyl Ether (C6E4) is a useful organic compound for research related to life sciences. The catalog number is TF0043 and the CAS number is 39619-69-7.

Bis-Tos-PEG4 (PROTAC Linker 16) is a PEG-based linker utilized in the synthesis of PROTACs.

Tr-PEG4-OH is a non-cleavable tetraethylene glycol ADC linker used in ADC synthesis for the conjugation of antibodies and drugs.

Amino-PEG4-Val-Cit-PAB-MMAE is a cleavable tetraethylene glycol (4 unit PEG) antibody-drug conjugate (ADC) linker used in the synthesis of ADCs[1].

DBCO-PEG4-acetic-Val-Cit-PAB is a cleavable tetraethylene glycol-based linker for antibody-drug conjugate (ADC) synthesis, featuring a dibenzocyclooctyne group, an acetic acid moiety, a valine-citrulline dipeptide, and a p-aminobenzyl alcohol end.

Endo-BCN-PEG4-Palmitic is a PEG derivative characterized by the inclusion of an endo-BCN cycloalkyne structure, a tetraethylene glycol (PEG4) linker, and a Palmitic acid fatty acid group. This compound is useful for drug delivery, surface modification, and click chemistry reactions.